Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 541 AL 555

Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits

Katariya RA, Sammeta SS, Kale MB, Kotagale NR, Umekar MJ, Taksande BG.

Ageing Res Rev. 2024 Apr;96:102269. doi: 10.1016/j.arr.2024.102269. Epub 2024 Mar 11.

Alzheimer's drugs, APPlication for Down syndrome?

Sokol DK, Lahiri DK.

Ageing Res Rev. 2024 Apr;96:102281. doi: 10.1016/j.arr.2024.102281. Epub 2024 Mar 19.

Formulating Treatment to Cure Alzheimer's Dementia: Approach #2

Fessel J.

Int J Mol Sci. 2024 Mar 20;25(6):3524. doi: 10.3390/ijms25063524.

Profiling lecanemab as a treatment option for Alzheimer's disease

Schiller ER, Silverglate BD, Grossberg GT.

Expert Rev Neurother. 2024 May;24(5):433-441. doi: 10.1080/14737175.2024.2333970. Epub 2024 Apr 3.

Physical activity improves the visual-spatial working memory of individuals with mild cognitive impairment or Alzheimer's disease: a systematic review and network meta-analysis

Deng J, Wang H, Fu T, Xu C, Zhu Q, Guo L, Zhu Y.

Front Public Health. 2024 Mar 28;12:1365589. doi: 10.3389/fpubh.2024.1365589. eCollection 2024.

The impact of physical exercise on hippocampal atrophy in mild cognitive impairment and Alzheimer's disease: a meta-analysis

Kress GT, Popa ES, Merrill DA, Bramen JE, Siddarth P.

Neuroreport. 2024 May 15;35(8):529-535. doi: 10.1097/WNR.0000000000002037. Epub 2024 Apr 12.

Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1

Fessel J.

Int J Mol Sci. 2024 Mar 31;25(7):3909. doi: 10.3390/ijms25073909.

[Role of NLRP3 inflammasome in prevention and treatment of cognitive impairment-related diseases and traditional Chinese medicine intervention: a review]

Wang CH, Wei XT, Zhao YQ, Wang DH, Xue JJ, Song ZQ, Tang F, Liu RX, Wang CA.

Zhongguo Zhong Yao Za Zhi. 2024 Feb;49(4):902-911. doi: 10.19540/j.cnki.cjcmm.20230913.403.

Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies

Cai J, Xie D, Kong F, Zhai Z, Zhu Z, Zhao Y, Xu Y, Sun T.

J Alzheimers Dis. 2024;99(1):53-84. doi: 10.3233/JAD-231249.

Effect of probiotics on cognitive function in adults with mild cognitive impairment or Alzheimer's disease: A meta-analysis of randomized controlled trials

Mo R, Jiang M, Xu H, Jia R.

Med Clin (Barc). 2024 Jun 28;162(12):565-573. doi: 10.1016/j.medcli.2024.01.013. Epub 2024 Apr 18.

The advent of Alzheimer treatments will change the trajectory of human aging

Selkoe DJ.

Nat Aging. 2024 Apr;4(4):453-463. doi: 10.1038/s43587-024-00611-5. Epub 2024 Apr 19.

Risk of Dementia and Alzheimer's Disease Associated With Antidiabetics: A Bayesian Network Meta-Analysis

Sunwoo Y, Park J, Choi CY, Shin S, Choi YJ.

Am J Prev Med. 2024 Sep;67(3):434-443. doi: 10.1016/j.amepre.2024.04.014. Epub 2024 May 4.

A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer's Disease

Parums DV.

Med Sci Monit. 2024 May 13;30:e945091. doi: 10.12659/MSM.945091.

Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer's

Song T, Wang Y, Silverglate BD, Grossberg GT.

Expert Opin Drug Metab Toxicol. 2024 Jun;20(6):411-417. doi: 10.1080/17425255.2024.2357637. Epub 2024 May 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias